References
- Van Berge Henegouwen M. I., Moojen T. M., Van Gulik T. M., Rauws E. A. J., Obertop H., Gouma D. J. Postoperative weight gain after standard Whipple’s procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. Br J Surg, 1998, 85: 922–6.
- Neoptolemos J. P., Russell R. C., Bramhall S., Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK pancreatic Cancer Group. Br J Surg, 1997, 84: 137–06.
- Trede M., Saeger H. D., Schwall G., Rumstadt B. Resection of pancreatic cancer-surgical achievements. Langenbecks Arch Surg, 1998, 383: 121–8.
- Cameron J. L., Pitt H. A., Yeo C. J., Lillemoe K. D., Kaufman H. S., Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg, 1993, 217: 430–5.
- Yeo C. J., Cameron J. L., Sohn T. A. et al. Six hundred fifty consecutive pancreaticoduodenectomies the, 1990s: pathology, complications, and oucomes. Ann Surg, 1997, 226: 248–57.
- Fernandez-del Castillo C., Rattner D. W., Warschaw A. L. Standards for pancreatic resection in the, 1990s. Arch Surg, 1995, 130: 295–9.
- Trede M., Carter D. C. The complications of pancreatoduodenectomy and their management. In: Trede M., Carter D. C. (eds.). Surgery of the Pancreas. Edinburgh: Churchill Livingstone, 1993, pp. 629–44.
- Gouillat C., Chipponit J., Baulieux J., Partensky C., Saric J., Gayet B. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg 2001, 88: 1456–62.
- Büchler M., Friess H., Klempa et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg, 1992, 163: 125–30.
- Pederzoli P., Bassi C., Falconi M., Camboni Mg. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg, 1994, 81: 265–9.
- LowY A. M., Lee J. E., Pisters P. W. et al. Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg, 1997, 226: 632–41.
- Yeo C. J., Cameron J. L., Lillemoe K. D. et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy ? Results of a prospective randomized placebo-controlled trial. Ann Surg, 2000, 232: 419–29.
- Schäfer M., Müllhaupt B., Clavien P. A. Evidence-Based Pancreatic Head Resection for Pancreatic Cancer and Chronic Pancreatitis. Ann of Surg, 2002, 236: 137–48.
- Li-Ling J., Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg, 2001, 88: 190–9.
- Friess H., Beger H. G., Sulkowski U. et al. Randomized controlled mulicentre study on the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg, 1995, 82: 1270–3.
- Yasuyuki S., Yasuhiro F., Yasuki T. et al. Selection of pancreati-cojejunostomy techniques according to pancreatic texture and duct size. Arch Surg, 2002, 137: 1044–7.
- Büchler W, Friess H, Wagner M, Kulli C, Wagener V, Z’graggen K. Pancreatic fistula after pancreatic head resection. Br J Surg, 2000, 87: 883–9.
- Heintges T., Luthen R., Niederau C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion, 1994, 55: 1–9.